A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer
Clinical trial NCT05780736 · TERMINATED
Trial details
- NCT number
- NCT05780736
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-08-04
- Primary completion
- 2024-08-23
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.